NCT02644278 2019-09-09First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With ChemotherapyEMD SeronoPhase 1 Completed15 enrolled 13 charts